Gsa Capital Partners LLP Organogenesis Holdings Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2024
A detailed history of Gsa Capital Partners LLP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 884,721 shares of ORGO stock, worth $2.64 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
884,721
Previous 531,218
66.55%
Holding current value
$2.64 Million
Previous $1.51 Million
64.26%
% of portfolio
0.17%
Previous 0.13%
Shares
12 transactions
Others Institutions Holding ORGO
# of Institutions
121Shares Held
60.5MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$34.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$34.3 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$10.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.07MShares$9.16 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $390M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...